Research & Development World

  • R&D World Home
  • Topics
    • Aerospace
    • Automotive
    • Biotech
    • Careers
    • Chemistry
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Software
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
    • Semiconductors
  • R&D Market Pulse
  • R&D 100
    • 2025 R&D 100 Award Winners
    • 2025 Professional Award Winners
    • 2025 Special Recognition Winners
    • R&D 100 Awards Event
    • R&D 100 Submissions
    • Winner Archive
  • Resources
    • Research Reports
    • Digital Issues
    • Educational Assets
    • R&D Index
    • Subscribe
    • Video
    • Webinars
    • Content submission guidelines for R&D World
  • Global Funding Forecast
  • Top Labs
  • Advertise
  • SUBSCRIBE

Epidemics Are Optional

By R&D Editors | December 11, 2014

The large number of deaths from the Ebola virus is primarily due to the lack of sufficient medical care where it’s needed most, Partners In Health’s Paul Farmer said at a public forum Monday.

Farmer, a Harvard professor and physician who has devoted his life to bringing health care to the poorest regions of Africa, drew attention to inaccurate perceptions around the spread of the epidemic, which has killed more than 6,000 people in 2014, mostly in Liberia and Sierra Leone.

Joining Farmer on the panel at Cambridge’s First Parish Church were Harvard’s Evelynn Hammonds, the Barbara Gutmann Rosenkrantz Professor of the History of Science and of African and African-American Studies; Ahmed Ragab, Richard T. Watson Assistant Professor of Science and Religion at Harvard Divinity School (HDS) and director of the Science, Religion, and Culture Program (SRC) at HDS; and David Jones, the A. Bernard Ackerman Professor of the Culture of Medicine at Harvard Medical School (HMS).

The forum prompted serious reflection about structural inequalities and how public perceptions get shaped, which often leads to how resources are directed. “The cost of believing that something is so lethal and fatal is significant,” Farmer said.

Hammonds drew attention to how perceptions of risk about Ebola had been shaped mostly through the media, while noting that epidemics “pull the covers off” the ways that the poor, vulnerable, and sick are perceived.

Farmer, who is the co-founder of Partners In Health, declared that rebuilding health systems has been his “biggest major commitment” in the last decade.

“We don’t make pledges lightly. This is a significant endeavor,” he stated. “We are looking for support.”

Answering questions about Harvard’s support, Farmer and Hammonds praised the University’s continued engagement. “Harvard is the biggest troop contributor,” said Farmer.

Ragab suggested that Harvard can engage more with the wider community, which was why the forum was held off campus at First Parish Church.

In a discussion that lasted more than 90 minutes, Farmer said that nobody should be dying of Ebola.

“If we had the staff, stuff, space, and systems, we could get people earlier into a place where they could get supportive care,” he said. To date, most Americans stricken with Ebola have survived because they were “scooped out” of miserable conditions, he said.

“I wouldn’t want to get care there. If I were to get Ebola, I would want to be airlifted back here ASAP. Or maybe to Europe,” he said.

What sped the spread of the disease, according to Farmer, was the lack of a health system that could provide adequate care. About 90 to 95% of Liberia does not have electricity, and there is a “tremendous amount of work” to be done to get the systems even to a level of mediocrity, he stated.

Yet, Farmer explained, “Outbreaks are inevitable. Epidemics are optional.”

Source: Harvard Medical School

Related Articles Read More >

Parallel Bio’s embraces in-house drug development as FDA backs animal testing alternatives
R&D 100 Winner Spotlight: A closer look at Thermo Fisher Scientific’s trio of R&D 100 wins in 2025
Life sciences M&A hit $240B in 2025 as Big Pharma preps for patent cliffs
Hansoh Bio signs 32,000-sq.-ft. lab lease at Research Square in Rockville, MD
rd newsletter
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest info on technologies, trends, and strategies in Research & Development.
RD 25 Power Index

R&D World Digital Issues

Fall 2025 issue

Browse the most current issue of R&D World and back issues in an easy to use high quality format. Clip, share and download with the leading R&D magazine today.

R&D 100 Awards
Research & Development World
  • Subscribe to R&D World Magazine
  • Sign up for R&D World’s newsletter
  • Contact Us
  • About Us
  • Drug Discovery & Development
  • Pharmaceutical Processing
  • Global Funding Forecast

Copyright © 2026 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search R&D World

  • R&D World Home
  • Topics
    • Aerospace
    • Automotive
    • Biotech
    • Careers
    • Chemistry
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Software
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
    • Semiconductors
  • R&D Market Pulse
  • R&D 100
    • 2025 R&D 100 Award Winners
    • 2025 Professional Award Winners
    • 2025 Special Recognition Winners
    • R&D 100 Awards Event
    • R&D 100 Submissions
    • Winner Archive
  • Resources
    • Research Reports
    • Digital Issues
    • Educational Assets
    • R&D Index
    • Subscribe
    • Video
    • Webinars
    • Content submission guidelines for R&D World
  • Global Funding Forecast
  • Top Labs
  • Advertise
  • SUBSCRIBE